CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Longsworth Todd Christopher General Counsel | Grant or award · Options to Buy Ordinary Shares | +6,106 | $80.59 | $492K | 6,106 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Grant or award | +21,508 | 63,312 | ||
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Sale | −1,149 | $74.50 | $86K | 62,163 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Grant or award · Options to Buy Ordinary Shares | +37,664 | $80.59 | $3.0M | 37,664 |
| 2022-03-03 | Cordova Ashley Chief Financial Officer | Grant or award · Options to Buy Ordinary Shares | +5,140 | $80.59 | $414K | 5,140 |
| 2022-03-03 | Weinberg Uri Chief Science Officer | Grant or award | +17,371 | 49,186 | ||
| 2022-03-03 | Weinberg Uri Chief Science Officer | Grant or award · Options to Buy Ordinary Shares | +30,422 | $80.59 | $2.5M | 30,422 |
| 2022-03-03 | Weinberg Uri Chief Science Officer | Grant or award · Options to Buy Ordinary Shares | +4,961 | $80.59 | $400K | 4,961 |
| 2022-03-03 | Shah Pritesh Chief Commercial Officer | Grant or award | +21,714 | 95,226 | ||
| 2022-03-03 | Shah Pritesh Chief Commercial Officer | Sale | −997 | $74.50 | $74K | 94,229 |
| 2022-03-03 | Shah Pritesh Chief Commercial Officer | Grant or award · Options to Buy Ordinary Shares | +38,027 | $80.59 | $3.1M | 38,027 |
| 2022-03-03 | Shah Pritesh Chief Commercial Officer | Grant or award · Options to Buy Ordinary Shares | +6,231 | $80.59 | $502K | 6,231 |
| 2022-03-03 | Danziger Asaf Chief Executive Officer | Grant or award · Options to Buy Ordinary Shares | +13,470 | $80.59 | $1.1M | 13,470 |
| 2022-03-03 | DOYLE WILLIAM F Executive Chairman | Grant or award · Options to Buy Ordinary Shares | +14,581 | $80.59 | $1.2M | 14,581 |
| 2022-03-03 | Benaim Ely Chief Medical Officer | Grant or award | +17,371 | 45,570 | ||
| 2022-03-03 | Benaim Ely Chief Medical Officer | Sale | −803 | $74.50 | $60K | 44,767 |
| 2022-03-03 | Benaim Ely Chief Medical Officer | Grant or award · Options to Buy Ordinary Shares | +30,422 | $80.59 | $2.5M | 30,422 |
| 2022-03-03 | Benaim Ely Chief Medical Officer | Grant or award · Options to Buy Ordinary Shares | +5,452 | $80.59 | $439K | 5,452 |
| 2022-03-03 | Burke William Patrick Chief Human Resources Officer | Grant or award | +7,445 | 58,395 | ||
| 2022-03-03 | Burke William Patrick Chief Human Resources Officer | Sale | −341 | $74.50 | $25K | 58,054 |
Page 23 of 32 · 638 trades